FeatureName:overall_survival|Type:SUR|StatisticMethod:Cox model|GroupComparison:|Statistics:   5.368398|Direction: 1|PValue:0.025020112|FDR:0.543777215;FeatureName:number_of_first_degree_relatives_with_cancer_diagnosis|Type:CAT|StatisticMethod:kruskal|GroupComparison:0/1/2/3|Statistics:   7.821233|Direction: 1|PValue:0.049854436|FDR:0.895219455;FeatureName:hypermutated|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics: 302.000000|Direction:-1|PValue:0.028684279|FDR:0.086676408;FeatureName:silent_mutrate|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.233652|Direction: 1|PValue:0.048229469|FDR:0.139664503;FeatureName:nonsilent_mutrate|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.317676|Direction: 1|PValue:0.006543692|FDR:0.036382929;FeatureName:CUBN_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics: 290.000000|Direction:-1|PValue:0.014419886|FDR:0.095445915;FeatureName:TP53_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics:1176.000000|Direction: 1|PValue:0.016069350|FDR:0.100194332;FeatureName:FAT4_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:1/0|Statistics: 825.000000|Direction: 1|PValue:0.017193338|FDR:0.429858669;FeatureName:20q11.21_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.398276|Direction:-1|PValue:0.000121534|FDR:0.000734491;FeatureName:20q12_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.358919|Direction:-1|PValue:0.000594753|FDR:0.002952525;FeatureName:8q24.21_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.212750|Direction:-1|PValue:0.046582331|FDR:0.561870348;FeatureName:5q22.3_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.234386|Direction: 1|PValue:0.027947907|FDR:0.431639900;FeatureName:20q13.31_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.375343|Direction:-1|PValue:0.000314107|FDR:0.001819203;FeatureName:16p11.2_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.280233|Direction:-1|PValue:0.008182704|FDR:0.027741362;FeatureName:1q31.1_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.246167|Direction:-1|PValue:0.020781377|FDR:0.247055791;FeatureName:16p13.3_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.215926|Direction:-1|PValue:0.043330725|FDR:0.223072990;FeatureName:18q21.2_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.332582|Direction: 1|PValue:0.001545916|FDR:0.007958602;FeatureName:5q22.2_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.226970|Direction: 1|PValue:0.033456309|FDR:0.422766090;FeatureName:18p11.31_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.229907|Direction: 1|PValue:0.031174362|FDR:0.085509883;FeatureName:8q11.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.216528|Direction:-1|PValue:0.042736724|FDR:0.881211470